Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCantab failure shows need for wide portfolio.AuthorsFletcher, LizAbstractReports on the failure of Cambridge, England-based Cantab's lead vaccine TH-GW for the treatment of genital warts. Impact of the vaccine failure on stock prices of the company; Analysts' assessment of the failure.SubjectsCAMBRIDGE (England); ENGLAND; VACCINES; CANTAB (Company); PHARMACEUTICAL industryPublicationNature Biotechnology, 2000, Vol 18, Issue 12, p1238ISSN1087-0156Publication typeArticleDOI10.1038/82331